FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988359292> ?p ?o ?g. }

• W1988359292 endingPage "2176" @default.
• W1988359292 startingPage "2169" @default.
• W1988359292 abstract "Objectives: Small bowel dysfunction in critically ill patients is frequent, underdiagnosed, and associated with poor prognosis. Intestinal fatty acid-binding protein is a marker of enterocyte damage, and plasma citrulline concentration is a marker of functional enterocyte mass. Primary objective was to identify factors associated with intestinal fatty acid-binding protein in critically ill patients. Secondary objectives were to study factors associated with plasma citrulline concentration and its correlation with intestinal fatty acid-binding protein. Design: Prospective observational study. Setting: ICU in a University Hospital Patients: Critically ill patients 18 years old or older with an expected length of ICU stay 48 hours or more, without pregnancy, chronic small bowel disease, or chronic renal failure. Interventions: None. Measurements and Main Results: Plasma intestinal fatty acid-binding protein and citrulline concentrations, and variables relating to prognosis and treatment, were measured at admission to the ICU. One hundred and three patients were included. Intestinal fatty acid-binding protein elevation at admission to the ICU was associated with catecholamine support, higher lactate concentration, higher Sequential Organ Failure Assessment score, and higher international normalized ratio (all p ≤ 0.001). Plasma citrulline concentration less than or equal to 10 μmol/L at admission to the ICU was associated with higher intra-abdominal pressure, higher plasma C reactive protein concentration, and more frequent antibiotic use (all p ≤ 0.005). There was no correlation between plasma levels of intestinal fatty acid-binding protein and citrulline. At ICU admission, Sequential Organ Failure Assessment score ≥12, plasma citrulline ≤ 12.2 μmol/L, and plasma intestinal fatty acid-binding protein concentration ≥355 pg/mL were all independently associated with 28-day mortality (odds ratio, 4.39 [1.48–13.03]; odds ratio, 5.17 [1.59–16.86]; and odds ratio, 4.46 [1.35–14.74], respectively). Conclusions: In critically ill patients, enterocyte damage is frequent, and it is significantly associated with shock and 28-day mortality. The link between intestinal fatty acid-binding protein and plasma citrulline concentrations in critically ill patients needs to be further evaluated." @default.
• W1988359292 created "2016-06-24" @default.
• W1988359292 creator A5004520435 @default.
• W1988359292 creator A5010266070 @default.
• W1988359292 creator A5017883658 @default.
• W1988359292 creator A5024214171 @default.
• W1988359292 creator A5060627956 @default.
• W1988359292 creator A5065485805 @default.
• W1988359292 creator A5083249962 @default.
• W1988359292 creator A5072203694 @default.
• W1988359292 date "2013-09-01" @default.
• W1988359292 modified "2023-10-09" @default.
• W1988359292 title "Enterocyte Damage in Critically Ill Patients Is Associated With Shock Condition and 28-Day Mortality*" @default.
• W1988359292 cites W1485767651 @default.
• W1988359292 cites W1542568082 @default.
• W1988359292 cites W1898928487 @default.
• W1988359292 cites W1986330043 @default.
• W1988359292 cites W1992098760 @default.
• W1988359292 cites W2000401504 @default.
• W1988359292 cites W2005276939 @default.
• W1988359292 cites W2006391664 @default.
• W1988359292 cites W2006560774 @default.
• W1988359292 cites W2013764208 @default.
• W1988359292 cites W2013803020 @default.
• W1988359292 cites W2014644469 @default.
• W1988359292 cites W2042900801 @default.
• W1988359292 cites W2050233503 @default.
• W1988359292 cites W2055491478 @default.
• W1988359292 cites W2099549162 @default.
• W1988359292 cites W2108709447 @default.
• W1988359292 cites W2119467481 @default.
• W1988359292 cites W2127204804 @default.
• W1988359292 cites W2153551421 @default.
• W1988359292 cites W2159067551 @default.
• W1988359292 doi "https://doi.org/10.1097/ccm.0b013e31828c26b5" @default.
• W1988359292 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23782971" @default.
• W1988359292 hasPublicationYear "2013" @default.
• W1988359292 type Work @default.
• W1988359292 sameAs 1988359292 @default.
• W1988359292 citedByCount "86" @default.
• W1988359292 countsByYear W19883592922013 @default.
• W1988359292 countsByYear W19883592922014 @default.
• W1988359292 countsByYear W19883592922015 @default.
• W1988359292 countsByYear W19883592922016 @default.
• W1988359292 countsByYear W19883592922017 @default.
• W1988359292 countsByYear W19883592922018 @default.
• W1988359292 countsByYear W19883592922019 @default.
• W1988359292 countsByYear W19883592922020 @default.
• W1988359292 countsByYear W19883592922021 @default.
• W1988359292 countsByYear W19883592922022 @default.
• W1988359292 countsByYear W19883592922023 @default.
• W1988359292 crossrefType "journal-article" @default.
• W1988359292 hasAuthorship W1988359292A5004520435 @default.
• W1988359292 hasAuthorship W1988359292A5010266070 @default.
• W1988359292 hasAuthorship W1988359292A5017883658 @default.
• W1988359292 hasAuthorship W1988359292A5024214171 @default.
• W1988359292 hasAuthorship W1988359292A5060627956 @default.
• W1988359292 hasAuthorship W1988359292A5065485805 @default.
• W1988359292 hasAuthorship W1988359292A5072203694 @default.
• W1988359292 hasAuthorship W1988359292A5083249962 @default.
• W1988359292 hasConcept C126322002 @default.
• W1988359292 hasConcept C2777468819 @default.
• W1988359292 hasConcept C2777882243 @default.
• W1988359292 hasConcept C2778384902 @default.
• W1988359292 hasConcept C2778426790 @default.
• W1988359292 hasConcept C2779129087 @default.
• W1988359292 hasConcept C2779604457 @default.
• W1988359292 hasConcept C515207424 @default.
• W1988359292 hasConcept C543025807 @default.
• W1988359292 hasConcept C55493867 @default.
• W1988359292 hasConcept C71924100 @default.
• W1988359292 hasConcept C78722104 @default.
• W1988359292 hasConcept C86803240 @default.
• W1988359292 hasConcept C90924648 @default.
• W1988359292 hasConceptScore W1988359292C126322002 @default.
• W1988359292 hasConceptScore W1988359292C2777468819 @default.
• W1988359292 hasConceptScore W1988359292C2777882243 @default.
• W1988359292 hasConceptScore W1988359292C2778384902 @default.
• W1988359292 hasConceptScore W1988359292C2778426790 @default.
• W1988359292 hasConceptScore W1988359292C2779129087 @default.
• W1988359292 hasConceptScore W1988359292C2779604457 @default.
• W1988359292 hasConceptScore W1988359292C515207424 @default.
• W1988359292 hasConceptScore W1988359292C543025807 @default.
• W1988359292 hasConceptScore W1988359292C55493867 @default.
• W1988359292 hasConceptScore W1988359292C71924100 @default.
• W1988359292 hasConceptScore W1988359292C78722104 @default.
• W1988359292 hasConceptScore W1988359292C86803240 @default.
• W1988359292 hasConceptScore W1988359292C90924648 @default.
• W1988359292 hasIssue "9" @default.
• W1988359292 hasLocation W19883592921 @default.
• W1988359292 hasLocation W19883592922 @default.
• W1988359292 hasOpenAccess W1988359292 @default.
• W1988359292 hasPrimaryLocation W19883592921 @default.
• W1988359292 hasRelatedWork W1659767363 @default.
• W1988359292 hasRelatedWork W1994125164 @default.
• W1988359292 hasRelatedWork W2053522842 @default.
• W1988359292 hasRelatedWork W2071449644 @default.
• W1988359292 hasRelatedWork W2089150532 @default.

• next